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June Supplement 201194S AbstractsMortality for OPEN was higher at LOW hospitals (14.5%
LOW vs. 9.2% HIGH; P0.01), while TEVAR mortality
was similar (4.6% LOW vs. 5.6% HIGH; PNS). LOW
volume increased mortality for OPEN (OR 1.39 [95%CI:
1.1-1.8]; P0.01) and not TEVAR. Hospital teaching
status remained stable over time and did not influence
OPEN or TEVAR mortality.
Conclusions: There has been a dramatic shift in DTA
repair away from OPEN with increasing use of TEVAR
even in low volume hospitals, wherein TEVAR has elimi-
nated the negative volume effect on perioperative out-
comes seen with OPEN. These data suggest OPEN repair
should be concentrated in high volume centers, whereas
TEVAR can be safely performed across a spectrum of
hospitals.
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Objectives: Whether abdominal aortic aneurysm
(AAA) enlargement after endovascular repair without an
identifiable endoleak is a risk factor for AAA rupture re-
mains controversial. To our knowledge, studies with large
patient numbers investigating this topic are missing. There-
fore, a considerable number of conversions to open AAA
repair have been performed in this patient group whichmay
not always be justified. The purpose of this study was to
evaluate AAA rupture risk in patients with AAA enlarge-
ment without detectable endoleaks after EVAR treatment
and when a watch-and-wait policy is allowed.
Methods: Baseline characteristics and follow-up data were
collected prospectively by case record forms. Follow-up visits,
were scheduled at 1, 6, 12, 18, 24 months and annually
thereafter. Findings at follow-up visits involved clinical
examination and imaging studies. Patients were divided
into three groups based on the degree of shrinkage or
enlargement. Group A represents patients with 8mm
aneurysm shrinkage, group B consisted of patients with
8mm shrinkage to8mm enlargement and group C had
an aneurysm enlargement of 8mm.
Results: 6337 patients who were enrolled prospec-
tively in the EUROSTAR database between 1996 and
2006 constituted the basis for this analysis. Group A in-
cluded 691 patients, group B 5307 patients and group C s39 patients. Ruptures occurred in 3 patients in group A,
4 patients in group B and 9 patients in group C. The
nnual rate of rupture in group C was 1% in the first 4
ears, but accelerated to 7.5 - 13.6% in the years thereafter.
he mortality rate of elective conversion to open AAA
epair was 6.7%.
Conclusions: The risk of rupture in patients with an
bdominal aneurysm enlargement of more than 8 mm
ithout detectable endoleaks is 1% in the first 4 years. A
onservative treatment policy in the first 4 years is therefore
dvisable. After 4 years of follow-up we see an increased
nnual rupture risk, however, groups are small and selec-
ion bias could play a role.
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Objectives: We hypothesized that surgeons who rarely
hunt in CEA have worse outcomes when shunt use is
equired, such as in contralateral carotid occlusion (CCO).
e studied the association between surgeon practice pat-
ern in shunt placement and 30-day stroke/death rate in
atients with CCO.
Methods: Of 6,084 CEAs performed in the Vascular
tudy Group of New England (2002-2009), 356 patients
nderwent CEA with CCO. We compared 30-day risk-
djusted stroke/death rate across surgeons who selectively
hunt (0-95% of CEA) or routinely shunt (95% of CEA).
Results: Of 356 patients with CCO, 117 patients
33%) underwent CEA without a shunt, 175 (49%) with
outine shunt use, and 64 (18%) had a shunt placed for a
eurologic indication. There was no difference in 30-day
troke/death rate by shunt use (3.1% no shunt; 4.1% rou-
ine shunt; 4.3% shunt for indication; p0.8). However,
cross surgeon practice pattern, the observed risk of 30-day
troke or death was higher for surgeons who rarely placed
hunts, and lower for surgeons who routinely placed shunts
Figure). This difference was not due to patient character-
stics, as the predicted risk of 30-day stroke/death was
imilar across surgeon practice patterns.
